These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33816228)

  • 1. A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma.
    Qi T; Meng X; Wang Z; Wang X; Sun N; Ming J; Ren L; Jiang C; Cai J
    Front Oncol; 2021; 11():595259. PubMed ID: 33816228
    [No Abstract]   [Full Text] [Related]  

  • 2. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
    Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ME2 Promotes Proneural-Mesenchymal Transition and Lipogenesis in Glioblastoma.
    Yang M; Chen X; Zhang J; Xiong E; Wang Q; Fang W; Li L; Fei F; Gong A
    Front Oncol; 2021; 11():715593. PubMed ID: 34381734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
    Li M; Xiao A; Floyd D; Olmez I; Lee J; Godlewski J; Bronisz A; Bhat KPL; Sulman EP; Nakano I; Purow B
    Oncotarget; 2017 Aug; 8(33):55319-55331. PubMed ID: 28903422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1.
    Yu S; Lv L; Li Y; Ning Q; Liu T; Hu T
    Mol Biol Rep; 2023 Oct; 50(10):8249-8258. PubMed ID: 37568042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions.
    Lai Y; Lu X; Liao Y; Ouyang P; Wang H; Zhang X; Huang G; Qi S; Li Y
    Genes Dis; 2024 Mar; 11(2):874-889. PubMed ID: 37692522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
    Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
    Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma.
    Sharma A; Bendre A; Mondal A; Muzumdar D; Goel N; Shiras A
    Front Oncol; 2017; 7():146. PubMed ID: 28744448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
    Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
    Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of
    Rathore S; Akbari H; Bakas S; Pisapia JM; Shukla G; Rudie JD; Da X; Davuluri RV; Dahmane N; O'Rourke DM; Davatzikos C
    Front Comput Neurosci; 2019; 13():81. PubMed ID: 31920606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma.
    Lin Z; Zhang Z; Zheng H; Xu H; Wang Y; Chen C; Liu J; Yi G; Li Z; Wang X; Huang G
    Cancer Cell Int; 2022 Apr; 22(1):151. PubMed ID: 35410293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma.
    He X; Zhang S; Chen J; Li D
    Cancer Med; 2019 May; 8(5):2031-2040. PubMed ID: 30848102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
    Olmez I; Love S; Xiao A; Manigat L; Randolph P; McKenna BD; Neal BP; Boroda S; Li M; Brenneman B; Abounader R; Floyd D; Lee J; Nakano I; Godlewski J; Bronisz A; Sulman EP; Mayo M; Gioeli D; Weber M; Harris TE; Purow B
    Neuro Oncol; 2018 Jan; 20(2):192-202. PubMed ID: 29048560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overexpression of GPX8 is correlated with poor prognosis in GBM patients.
    Li S; Jiang X; Guan M; Zhang Y; Cao Y; Zhang L
    Front Genet; 2022; 13():898204. PubMed ID: 36061208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype.
    Chelebian E; Fuster-Garcia E; Álvarez-Torres MDM; Juan-Albarracín J; García-Gómez JM
    PLoS One; 2020; 15(10):e0232500. PubMed ID: 33052913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
    Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
    Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
    Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
    Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?
    Soike MH; McTyre ER; Shah N; Puchalski RB; Holmes JA; Paulsson AK; Miller LD; Cramer CK; Lesser GJ; Strowd RE; Hinson WH; Mott RT; Johnson AJ; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
    Neuroradiology; 2018 Oct; 60(10):1043-1051. PubMed ID: 30094640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.
    Kaffes I; Szulzewsky F; Chen Z; Herting CJ; Gabanic B; Velázquez Vega JE; Shelton J; Switchenko JM; Ross JL; McSwain LF; Huse JT; Westermark B; Nelander S; Forsberg-Nilsson K; Uhrbom L; Maturi NP; Cimino PJ; Holland EC; Kettenmann H; Brennan CW; Brat DJ; Hambardzumyan D
    Oncoimmunology; 2019; 8(11):e1655360. PubMed ID: 31646100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.